PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Royal DSM N.V.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

DSM Rises Rapidly in Biofuels Digest’s ‘Hot’ Bioenergy and Renewable Chemicals Polls - Royal DSM, the global Life Sciences and Materials Sciences company, received top-10 honors this week in Biofuels Digest’s prestigious ‘50 Hottest Companies In Bioenergy’ and ‘30 Hottest In Renewable Chemicals’ polls - DSM.com
DSM Rises Rapidly in Biofuels Digest’s ‘Hot’ Bioenergy and Renewable Chemicals Polls

 

NewswireToday - /newswire/ - Delft, Netherlands, 2013/10/11 - Royal DSM, the global Life Sciences and Materials Sciences company, received top-10 honors this week in Biofuels Digest’s prestigious ‘50 Hottest Companies In Bioenergy’ and ‘30 Hottest In Renewable Chemicals’ polls - DSM.com. Euronext: DSM KON

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The company finished in 10th spot in the magazine’s Bioenergy poll, joining our joint venture partner POET in the top 10, and grabbed 7th position in the Renewable Chemicals contest, beating established industry peers DuPont and Novozymes for the first time in both contests.
Biofuels Digest Awards

“We’re honored to have been placed so highly among our peers in these polls, which recognize the pioneering contribution we’re making towards a sustainable, bio-based economy,” said Anton Robek, President DSM Bio-based Products & Services. “Our efforts are increasingly helping many manufacturers and consumers around the world to reduce their dependence on fossil-based feedstocks in energy and in commerce, reducing their carbon footprint and ultimately providing a better environment for all of us.”

The polls, based on industry professionals in the biofuels and bio-chemical industries votes, have been conducted for the last four years and show an upward progression for DSM’s perception in these industries. Previously, DSM was ranked outside the ‘Hot 50’ and 24th for the last two years in the Bioenergy poll, and 20th and 13th in the Renewable Chemicals poll.

DSM Bio-based Products & Services
DSM is a frontrunner in creating bio-based and environmentally sound solutions within its Bio-based Products and Services unit. DSM focuses on enabling technology in biofuels and bio-based chemicals and materials made from renewable biomass, and demonstrating the commercial viability of these technologies in collaboration with strategic partners along the value chain.

DSM aims to develop competitive solutions that also deliver significant improvement in carbon footprints measured by Life Cycle Analysis. DSM’s joint venture with ethanol major POET will demonstrate production of cellulosic bio-ethanol from corn-crop residue in Project Liberty.

DSM (dsm.com) also developed a novel low pH fermentative route to produce high-quality bio-based succinic acid, and with joint-venture partner Roquette Frères operates a 10 kiloton plant in Italy the first of its scale in the world.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Royal DSM N.V.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


DSM Rises Rapidly in Biofuels Digest’s ‘Hot’ Bioenergy and Renewable Chemicals Polls

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Royal DSM N.V. |
Publisher Contact: Joost Dubois - DSM.com 
+31 (0)6 204 37998 joost.dubois[.]dsm.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Royal DSM N.V. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Royal DSM N.V. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)